H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs SCIEGEN PHARMACEUTICALS, INC.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513
Entity B
SCIEGEN PHARMACEUTICALS, INC.
NYRank #FEIN 30-0597093

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPSCIEGEN PHARMACEUTICALS, INC.
Total filings80,813353
Certified %98.23%98.02%
Denied %1.09%0.57%
Withdrawn %0.61%1.13%
Cert-withdrawn %0.07%0.28%
Rank#4
Active yearsFY2010–FY2026FY2011–FY2026
Worksite statePANY

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Outcomes — SCIEGEN PHARMACEUTICALS, INC.

DOL case-status mix.

Outcome breakdown: Certified 98.0%, Cert-withdrawn 0.3%, Withdrawn 1.1%, Denied 0.6%
Outcome breakdown
OutcomeShare
Certified98.0%
Cert-withdrawn0.3%
Withdrawn1.1%
Denied0.6%
Certified98.0%
Cert-withdrawn0.3%
Withdrawn1.1%
Denied0.6%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612
SCIEGEN PHARMACEUTICALS, INC.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY201129
FY20121
FY20131
FY201426
FY201528
FY201631
FY201747
FY201833
FY201942
FY20200
FY202118
FY20224
FY20232
FY202417
FY202535
FY202639

Top 5 occupations — Deloitte Consulting LLP

Top 5 occupations — SCIEGEN PHARMACEUTICALS, INC.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.